Related Experiment Videos
ALK-Negative Systemic Anaplastic Large Cell Lymphoma with Cutaneous Involvement Initially Mimicking Primary Cutaneous
Huijing Wang1, Zongyang Li1, Shubo Zhuang1
1Department of Cosmetic Dermatology, The First Hospital of Tsinghua University, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, People's Republic of China.
Abstract:
Anaplastic large cell lymphoma (ALCL), a subgroup of T-cell non-Hodgkin's lymphoma, is a relatively uncommon malignancy with a highly variable prognosis. Systemic ALK-negative status and high Ki-67 expression are generally associated with poor outcomes in ALCL patients. Systemic ALK-negative ALCL presenting initially with cutaneous involvement is rare, with only a few cases reported in the literature. The aggressive clinical course of systemic ALK-negative ALCL with cutaneous lesions contrasts sharply with the indolent behavior of primary cutaneous ALCL (C-ALCL). Accurate distinction requires integration of histopathological and immunophenotypic findings. In particular, negativity for cutaneous lymphocyte antigen (CLA) is a useful discriminator, as primary C-ALCL typically expresses CLA while systemic cases often do not. Accumulating more clinical data is essential to better characterize this entity and guide therapeutic decisions. Here, we report a case of aggressive ALK-negative systemic ALCL that presented with cutaneous nodules as the initial manifestation, clinically mimicking primary C-ALCL.